Toxic pelvic cavity in endometriosis, a new frontier for medical therapies

Reflections

Published May 17, 2018

Editorial Office, American Society for Reproductive Medicine

Toxic pelvic cavity in endometriosis, a new frontier for medical therapies

Volume 110, Issue 4, Pages 644–645

Authors:

Dominique de Ziegler, M.D., Paul Pirtea, M.D., Marine Poulain, Pharm.D., Ph.D., Marie Carbonel, M.D., Marc Even, M.D., Jean Marc Ayoubi, M.D., Ph.D.

Abstract:

Reflections on "Elevated peritoneal fluid ceramides in human endometriosis-associated infertility and their effects on mouse oocyte maturation" by Lee et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.

Fertility and Sterility Dialog

Toxic pelvic cavity in endometriosis, a new frontier for medical therapies

Volume 110, Issue 4, Pages 644–645

Authors:

Abstract:

Recommended Content

A case of didelphys uterus: tackling the double trouble adenomyosis and infertility

Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score–matched study

Reply of the authors: is the era of the endometrial scratching finished?

Can we disregard geography when using the World Health Organization semen analysis reference ranges?

Association between embryo morphological quality and birth weight for singletons conceived via autologous fresh embryo transfer: an analysis using Society for Assisted Reproductive Technology Clinical Outcomes Reporting System